Quick Answer
AVAI BIO, INC. reported Operating Income of -$1.14 million for fiscal year 2025.
AVAI BIO, INC. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$1.14M | +46.3% |
| 2024 | -$2.13M | -510.0% |
| 2023 | -$348.9K | -375.8% |
| 2022 | $126.5K | -58.1% |
| 2021 | $302.3K | +334.4% |
| 2020 | $69.6K | +189.0% |
| 2019 | -$78.2K | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | -$553.7K | -222.4% | -22.2% |
| September 30, 2025 | -$453.0K | -172.7% | +7.1% |
| June 30, 2025 | -$487.6K | +7.8% | -207.8% |
| December 31, 2024 | $452.3K | -55.4% | -27.4% |
| September 30, 2024 | $623.0K | +55.9% | +217.8% |
| June 30, 2024 | -$528.8K | -228.5% | -152.2% |
| December 31, 2023 | $1.01M | +817.8% | +153.7% |
| September 30, 2023 | $399.6K | +377.1% | -2.9% |
- AVAI BIO, INC. showed an increase of +46.3% in Operating Income compared to the prior fiscal year.
- Over the 2019–2025 period, AVAI BIO, INC.’s operating income has declined by 1360.0% (from -$78.2 thousand to -$1.14 million).
- The most recent figure is from AVAI BIO, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on July 8, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: